Jemperli is the first and only approved programmed death receptor-1 (PD-1) immunotherapy for the second-line treatment of ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

GlaxoSmithKline (GSK) has entered India's oncology sector with the launch of Jemperli and Zejula. These therapies address the increasing need for specialized cancer treatments.

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast cancers are treated in the future ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

GlaxoSmithKline (GSK) has announced its foray into oncology in India with the launch of Jemperli (dostarlimab) and Zejula (niraparib). Jemperli is the first and only approved PD-1 immunotherapy for ...

Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- ...

Karen Thursby, a Darlington -based yoga teacher who lost her mother Lola to bile duct cancer in 2017, has been organising ...

Loni Anderson's cause of death was metastatic uterine leiomyosarcoma, a rare and aggressive form of cancer. She passed away ...

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...

The National Cancer Institute of the National Institutes of Health has awarded Dr. Anna Gottschlich, assistant professor of oncology in the Wayne State University School of Medicine and the Barbara ...